Art

J-GLOBAL ID：202002290958716768   Reference number：20A0800363

Successful retreatment with 12 weeks of glecaprevir and pibrentasvir for a genotype 2a HCV-infected hemodialysis patient who failed to respond to 8 weeks of prior glecaprevir and pibrentasvir therapy

以前の8週間のグレカプレビルおよびピブレンタスビル療法に反応しなかった遺伝子型2a HCV感染血液透析患者に対する12週間のグレカプレビルおよびピブレンタスビルの再治療の成功

Author (16)： Ohya Kazuki (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Imamura Michio (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Osawa Mitsutaka (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Teraoka Yuji (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Morio Kei (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Fujino Hatsue (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Ono Atsushi (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Nakahara Takashi (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Murakami Eisuke (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Yamauchi Masami (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Kawaoka Tomokazu (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Hiramatsu Akira (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Tsuge Masataka (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Aikata Hiroshi (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Hayes Clair Nelson (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan) ,  Chayama Kazuaki (Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan)
Material： Clinical Journal of Gastroenterology (Web)
Volume： 13  Issue： 2  Page： 267-270  Publication year： 2020 
JST Material Number： U1136A  ISSN： 1865-7257  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： C型肝炎ウイルス2a ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0800363&from=J-GLOBAL&jstjournalNo=U1136A") }}

Author keywords (5)： HCV ,  Glecaprevir ,  Pibrentasvir ,  Hemodialysis ,  Retreatment

JST classification (3)： Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G) ,  Treatment for infectious diseases,parasitic diseases.  (GD01030D) ,  Other therapies for urogenital diseases  (GM05040R)

Substance index (1)： Glecaprevir/Pibrentasvir

Terms in the title (8)： グレカプレビル ,  ピブレンタスビル ,  療法 ,  遺伝子型 ,  HCV感染 ,  血液透析患者 ,  再治療 ,  成功